No study has measured how much bisphenol A migrates from a headphone ear pad to your skin per hour of use.
The content has been measured. In February 2026, the ToxFREE consortium — funded by the EU LIFE Programme — tested 81 headphone models from five European markets. Every single model contained hazardous chemicals. BPA was detected in 177 of 180 plastic samples. The maximum concentration was 351 mg/kg.1
But content is not exposure. Content tells you what the reservoir holds. Migration tells you what the body receives. For food packaging, the EU requires both measurements. For headphones — pressed against skin for hours daily, in warm, moist, sealed conditions — it requires neither.
This report does not claim headphones cause harm. It demonstrates that the conditions, materials, and pharmacokinetic pathways for harm exist — and that the measurement to assess risk does not.
What the Study Found
The ToxFREE study — "The Sound of Contamination," published February 18, 2026, ISBN 978-80-88508-94-6 — analysed 180 samples of hard and soft plastic components from 81 headphone models sold in the Czech Republic, Slovakia, Hungary, Slovenia, and Austria, plus products from Shein and Temu.1
| Chemical Class | Prevalence | Maximum Concentration |
|---|---|---|
| Bisphenol A (BPA) | 177 of 180 samples (98%) | 351 mg/kg |
| Bisphenol S (BPS) | >75% of samples | Not quantified in public briefing |
| Phthalates | Present across models | Not quantified |
| Chlorinated paraffins | Present across models | Not quantified |
| Organophosphate flame retardants | Present | Not quantified |
Brands tested included Bose (QuietComfort), Sennheiser (Momentum Wireless 4), Samsung (Galaxy Buds3 Pro), Sony (WF-1000XM5), Jabra (Elite 10 Gen 2), and Beats (Solo 4).1 Premium brands showed equal contamination to budget brands. Price is not a proxy for chemical safety.
Sennheiser responded that "all our headphones undergo rigorous testing to ensure applicable safety and quality standards are met."1 The applicable safety standards do not require BPA testing, BPA limits, or migration testing for headphones.
The 351 mg/kg figure is 35 times the 10 mg/kg limit originally proposed by Germany under REACH for BPA in consumer articles — a proposal Germany withdrew in August 2023 before it became binding.2 The comparison is to a standard that was considered, then shelved. No enforceable BPA limit exists for headphones in any jurisdiction.
BPA Is the Material
BPA is not a contaminant found in headphones. BPA is headphones.
Polycarbonate — the dominant hard plastic in headphone housings, hinges, and structural elements — is synthesised from bisphenol A. BPA is the monomer building block: two phenol groups linked by a propane bridge, polymerised with phosgene or diphenyl carbonate to form the polymer chain.3 BPA is to polycarbonate what flour is to bread. The ToxFREE finding that 98% of samples contained BPA is not a manufacturing failure. It is a material identity.
The 351 mg/kg represents residual unreacted monomer — BPA molecules that did not polymerise during manufacturing — plus monomer liberated from the polymer chain through hydrolysis over time.3 The Danish Environmental Protection Agency documented polycarbonate as a standard headphone housing material as early as 2008.4 The material was chosen for transparency, impact resistance, and heat tolerance — before anyone thought to test what it releases against skin.
The highest BPA concentrations in the ToxFREE study appeared in hard plastic components, consistent with polycarbonate being the primary reservoir.1 ABS, the other common headphone plastic, does not inherently contain BPA but may use tetrabromobisphenol A (TBBPA) as a flame retardant — a BPA derivative.4
This reframes the consumer question. "BPA-free headphones" would require replacing polycarbonate entirely — with Eastman Tritan copolyester, for instance, which is commercially available for wearable electronics applications and marketed specifically for headphone bands.5 The question is not whether the BPA can be removed from the plastic. It cannot. The question is whether the plastic can be replaced.
The Accidental Patch
The pharmaceutical industry spent decades engineering a way to deliver drugs through skin into the bloodstream. They wanted to bypass the liver — which deactivates most oral drugs before they reach circulation — and achieve sustained, controlled delivery over hours. The result was the transdermal drug patch: an occluded, warm, moist, lipophilic delivery system pressed against skin.
Headphone ear pads create these conditions by accident.
In Report 035, we named the exposure class: occluded skin against polymer, in a coupled thermal-moisture microclimate, for hours daily.6 Headphone ear pads match that framework. What headphones introduce is a pharmacokinetic dimension: the primary chemical in the reservoir — BPA — behaves differently depending on how it enters the body.
The Liver Bypass
When BPA is swallowed — in food, from a container, in water — it passes through the liver before entering general circulation. The liver conjugates it: attaches a glucuronic acid molecule that deactivates the compound. This first-pass metabolism is efficient. According to a pharmacokinetic study conducted by the US EPA, NIEHS, and NIH, approximately 99.6% of orally ingested BPA is conjugated by the liver into an inactive form [human biomonitoring].7
When BPA is absorbed through the skin, it enters the bloodstream directly. The liver never sees it.
This is not a novel finding. It is the reason transdermal drug patches exist. The pharmaceutical literature states it plainly: transdermal delivery "circumvents" hepatic first-pass metabolism, "allowing direct entry into the systemic circulation."8 BPA — molecular weight 228 daltons, lipophilic (log Kow 3.32, a measure of how readily a chemical dissolves in fats versus water; higher values indicate greater fat solubility), non-ionic — meets every pharmaceutical criterion for a transdermal delivery candidate.8
The Numbers
In 2020, Thayer and colleagues at the US EPA and NIEHS published the first controlled human study of BPA dermal pharmacokinetics. Ten subjects received 100 micrograms per kilogram of deuterium-labelled BPA applied to forearm skin under occlusive chambers for 12 hours [human biomonitoring].7
| Parameter | Dermal Exposure | Oral Exposure | Ratio |
|---|---|---|---|
| Free (bioactive) BPA as % of total at peak blood concentration | 10.9% (range: 6.6-17%) | 0.39% | ~28x |
| Free (bioactive) BPA as % of total systemic exposure (AUC) | 8.81% | 0.56% | ~16x |
| Terminal half-life of total BPA | 21.4 hours | ~6.4 hours | ~3.3x longer |
| Systemic availability (total BPA reaching circulation) | ~2.2% of applied dose | ~100% of oral dose | Oral is ~45x higher |
Two numbers matter. First: only about 2.2% of BPA applied to skin reaches systemic circulation, compared to nearly all of an oral dose. The skin is a barrier, and most of the applied BPA stays on the surface or in the upper skin layers [human biomonitoring].7
Second: of the BPA that does reach circulation dermally, approximately 16 times more remains in its bioactive, unconjugated form — the form that mimics estrogen, binds hormone receptors, and produces endocrine effects [human biomonitoring].7 The liver's conjugation step, which deactivates 99.6% of oral BPA, does not engage for the dermal route.
What bioactive BPA does in the body. BPA binds estrogen receptors (ER-alpha, ER-beta), androgen receptors, and thyroid hormone receptors [in vitro].27 Chronic BPA exposure is associated with reproductive developmental abnormalities, including earlier puberty onset [animal, human biomonitoring].19 At nanomolar concentrations, BPA stimulates proliferation of both ER-positive and ER-negative breast cancer cells [in vitro].27 BPA disrupts thyroid function by interfering with thyroid hormone signalling [animal, human biomonitoring].19 Metabolic effects include insulin resistance and altered glucose homeostasis [animal, epidemiological].19 These outcomes are why the 16x bioactive multiplier matters: it is not an abstract pharmacokinetic ratio. It describes how much more of the BPA that reaches circulation remains in the form capable of producing these effects.
A smaller dose that is 16 times more potent per unit absorbed. Whether that trade-off produces a net increase or decrease in biological effect depends entirely on how much BPA migrates from the ear pad to the skin — the measurement that does not exist.
The Depot
The pharmacokinetic study revealed a second finding. Dermally absorbed BPA does not clear quickly. The terminal half-life is 21.4 hours — more than three times longer than oral BPA's 6.4 hours [human biomonitoring].7 Urinary BPA excretion increased linearly for two full days after a single dermal exposure. Half the participants still had detectable urinary BPA after one week.7
The skin acts as a reservoir — a depot that slowly releases BPA into circulation long after the headphones come off.
For a daily commuter wearing headphones four to eight hours each morning, the arithmetic is straightforward. Monday's depot is still releasing BPA into circulation when Tuesday's exposure begins. Tuesday's overlaps with Wednesday's. By Friday, five overlapping depot contributions are summing in the bloodstream. The conventional pharmacokinetic models for BPA — built on oral exposure data with a 6.4-hour half-life — do not predict this accumulation pattern. No regulator has modelled it for headphone use because no regulator has measured the initial migration rate.
The Extraction Medium
What draws BPA out of the polymer and into the skin?
The ear and periauricular area — the skin contacted by over-ear headphone pads — sits within a region of exceptionally high oil-gland density. Scalp and facial skin contains 400-900 sebaceous glands per square centimetre, compared to approximately 100 per square centimetre on the limbs and trunk; the periauricular zone, adjacent to both, shares this high-density profile.10 Sebum — the oily secretion of these glands — is the key.
In 2023, Abafe, Harrad, and Abdallah at the University of Birmingham demonstrated that sebum specifically facilitates chemical extraction from polymer matrices. In experiments using synthetic sweat-sebum mixtures at physiological temperature (32°C) and skin pH (5.3), sebum dramatically increased chemical extraction from plastics compared to sweat alone [in vitro].11 In a follow-up study using three-dimensional human skin equivalent models, up to 8% of the bioaccessible chemical fraction was absorbed through the skin, with more hydrated skin absorbing higher levels [in vitro].12
BPA, phthalates, and flame retardants are all lipophilic — they preferentially dissolve in fats and oils.11 Sebum is a lipid medium. The ear pad seals against sebum-rich skin, creating a warm, moist, occluded microenvironment. Body heat raises the temperature. Eccrine sweat glands produce acidic perspiration (pH 4.5-7.0) that accelerates polymer hydrolysis. Sebaceous glands coat the skin-plastic interface with the extraction medium. The chemical crosses the skin. The liver never sees it.
This is not a metaphor. It is a description of the conditions pharmaceutical companies deliberately create when they design transdermal drug patches.8
| Condition | Pharmaceutical Transdermal Patch | Headphone Ear Pad |
|---|---|---|
| Occlusion | Adhesive backing seals skin | Ear pad seals against periauricular skin |
| Sustained contact | 12-72 hours, prescribed | 3-8 hours daily, habitual |
| Warm, moist environment | Body heat + occlusion | Body heat + sweat + sealed microclimate |
| Lipophilic reservoir | Drug in lipid-soluble carrier | BPA, phthalates, FRs in polymer matrix |
| Extraction medium | Engineered adhesive | Sebum (natural lipophilic secretion) |
| Liver bypass | Intended — the design purpose | Unintended — pharmacokinetically identical |
| Dose control | Precisely engineered | Unknown — no migration testing exists |
| Pharmacokinetic assessment | Required (FDA/EMA) | None conducted; none required |
Ear pads are not engineered patches. They lack permeation enhancers, controlled-release matrices, and adhesive seals. The comparison is not about delivery efficiency — it is about delivery conditions and the regulatory asymmetry that follows. A product need not be as efficient as a pharmaceutical patch to warrant the testing a pharmaceutical patch requires.
During exercise, the system intensifies. Eccrine sweat output increases. Sebaceous output rises. Skin temperature elevates. Vasodilation increases blood flow through the dermis, accelerating systemic uptake of anything that crosses the skin barrier [in vitro, animal].11 The ear pad creates a hot, sealed, moist, sebum-rich environment against the skin — the maximum extraction conditions. According to a Mimi Hearing Technologies survey, 57% of headphone users wear them during exercise.13
The Hydrolysis Clock
Headphones do not present the same chemical profile on day one and day one thousand.
Polyurethane foam — the universal material for over-ear ear cushions and headband padding — degrades through hydrolysis: water molecules break the polymer chains.14 Human sweat is an accelerant. The acid medium (pH 4.5-7.0) catalyses the reaction. The process is autocatalytic: when polyester bonds break, they revert to acid and alcohol groups, adding more acid to the system, speeding the next round of degradation.14
Every headphone user has seen the result. The ear pads crack. They flake. They crumble. Audio-Technica classifies ear pads and headband pads as "perishable items" with a normal lifetime of up to around five years, reduced with heavy use.15
The visible degradation is interpreted as a comfort problem. It is a chemical exposure event.
Three things happen simultaneously as PUR foam degrades. First, the hydrolysis itself releases degradation products — glycol derivatives, alcohol fragments, acid fragments — that are additional chemical exposures at the skin surface.14 Second, the foam barrier thins. The soft pad that separates skin from the BPA-rich hard polycarbonate housing underneath becomes thinner, bringing the primary chemical reservoir closer to direct skin contact. Third, the cracking and crumbling generates micro- and nano-scale polyurethane particles at the skin surface — microplastics formed in situ, carrying whatever additives were embedded in the original foam.16
TIMELINE OF PERSISTENCE
- Time on ears: 3-8 hours daily
- Time in drawer between uses: 16-21 hours (dermal depot still releasing)
- Time before ear pads visibly degrade: 2-5 years
- Time BPA persists in environment: 100+ years
- Time before regulation (if historical pattern holds): 20-50 years
The softness that makes the ear pad comfortable is the polyurethane foam that hydrolyses against your skin. The comfort feature is the chemical exposure mechanism.
Consumers who replace degrading ear pads with aftermarket alternatives — a thriving market served by Wicked Cushions, Dekoni Audio, Brainwavz, and thousands of unbranded Amazon listings — may be restarting the chemical exposure clock with fresh material that has even less chemical oversight than the original equipment.17
The Classification Trap
If the conditions, materials, and pharmacokinetics exist, why has nobody measured the migration?
Because nobody has to. Headphones are classified as consumer electronics under REACH and RoHS — the same regulatory category as televisions, which never touch skin.2
| Product | Typical Daily Skin Contact | BPA Regulation | Migration Testing Required |
|---|---|---|---|
| Food packaging | Seconds (indirect, via food) | Banned (EU, Jan 2025) | Yes — food simulants |
| Baby dummies | Hours (mouth contact) | Migration limit: 0.04 mg/l | Yes — saliva simulant |
| Children's toys | Hours | Migration limit (under-3s) | Yes — sweat/saliva |
| Jewellery / watch cases | Hours | Metal ion release limits | Yes — artificial sweat (ISO 3160-2) |
| Headphones | 3-8 hours daily | None | None |
The product with the longest daily skin contact duration in this table has the least chemical safety testing. Not because the science doesn't support testing — but because the product classification was set before headphones became wearables.
The artificial sweat standard ISO 3160-2 — a solution of sodium chloride, ammonium chloride, acetic acid, and lactic acid at pH 4.7 — is routinely used to test metal ion release from jewellery and watch cases.18 It could be applied to headphone polymer materials with minimal adaptation. The methodology exists. The regulatory mandate does not.
Germany attempted to close this gap. In October 2022, it proposed restricting bisphenols in consumer articles under REACH Annex XVII, with a limit of 10 mg/kg.2 The ToxFREE study found headphone concentrations 35 times this proposed limit. Germany withdrew the proposal in August 2023, citing the need for further work.2 No resubmission date has been announced.
In April 2023, the European Food Safety Authority re-evaluated BPA and lowered the tolerable daily intake by a factor of 20,000 — from 4 micrograms per kilogram of body weight per day to 0.2 nanograms.19 At this level, EFSA concluded that all age groups exceed safe BPA exposure from dietary sources alone — before any dermal contribution from headphones, receipts, or other sources is counted.19 Germany's BfR publicly disputed this reduction, but the Accidental Patch argument does not depend on which TDI is correct. It depends on the pharmacokinetic difference between dermal and oral exposure — which neither agency disputes.
This investigation continues below.
Want the next one in your inbox?
Children's headphones occupy a particular gap. A toy that a child places in their mouth is covered by the Toy Safety Directive, with BPA migration limits.2 Headphones that sit on a child's head for hours daily are classified as electronics, not toys, and are exempt.2 According to a University of Michigan Mott Poll, 16% of children use audio devices for more than two hours daily, with a further 24% using them for one to two hours.13
The Apple Comparison
Apple publishes a "Restricted Chemicals for Prolonged Skin Contact Materials" specification for Apple Watch.21 The specification restricts phthalates (DINP, DIDP, and others) and PFHxA in wearable devices. Apple requires Full Material Disclosure from suppliers, conducts independent material characterisation testing, and employs toxicologists to assess every skin-contact material.21
Apple's own rationale, stated in their documentation: customers often wear Apple Watch for more than 12 hours per day.21 This is the same exposure profile as headphones.
No audio brand — not Bose, not Sennheiser, not Sony, not Jabra — has published an equivalent specification for headphone ear pads.1 Whether Apple's own AirPods are covered by the Watch specification is not confirmed in publicly available documentation.
Apple restricted chemicals in the Watch because the Watch is marketed as a health device. No audio brand has applied the same framework to headphones — devices with a comparable skin-contact profile. Apple's specification proves three things: restricting hazardous chemicals in consumer electronics is technically feasible, economically viable at consumer electronics margins, and the testing infrastructure exists.
The Provocation
A BPA-specific migration test — measuring transfer from polymer to artificial sweat simulant under standardised conditions — costs approximately $318 per sample, according to published pricing from accredited testing laboratories.22 A comprehensive chemical safety panel covering BPA, phthalates, and flame retardants across three headphone components (ear pad, headband, housing) would cost roughly $2,000-4,000 per headphone model.22
Bluetooth SIG product qualification — the wireless certification every headphone model must obtain before it can connect to a phone — costs $8,000 per product listing.23
The test that would tell you what chemicals reach your skin costs less than the certification that lets your headphones talk to your phone.
Apple paid $3 billion to acquire Beats in 2014.24 The migration test that would answer The Question costs approximately one ten-millionth of that acquisition price.
No manufacturer among the 81 brands tested by ToxFREE has published migration testing results for skin-contact components.
The Counter-Position
The strongest defence of the current system is straightforward: content is not exposure.
Polycarbonate is a tight, non-crystalline polymer — its molecular chains are packed closely, without the open crystalline structure that would allow chemicals to migrate freely. Unlike PVC — which freely leaches plasticiser additives — polycarbonate holds BPA in its backbone structure. Only residual unreacted monomer and surface-hydrolysed monomer are mobile. BPA migration from new polycarbonate baby bottles into water at 40°C has been measured at 0.03-0.18 parts per billion — very low relative to the content in the material [in vitro].25 If headphone ear pad migration rates are similarly low, the 16x bioactive multiplier becomes clinically irrelevant: 16 times a negligible dose is still a negligible dose.
This defence is legitimate. It is also incomplete.
The baby bottle studies used water as the extraction medium. Headphone ear pads contact sebum-rich skin — a lipophilic extraction environment fundamentally different from aqueous media. The Birmingham data demonstrates that sebum extracts lipophilic chemicals from polymer matrices at dramatically higher rates than aqueous conditions [in vitro].11 Baby bottles are heated but not occluded; headphones are occluded but not heated to boiling. The extraction conditions are not comparable.
The pharmacokinetic study by Thayer and colleagues — the basis of the 16x bioactive finding — used direct application of BPA solution to forearm skin under occlusive chambers, not polymer-to-skin migration [human biomonitoring].7 The actual dose of BPA migrating from a polycarbonate ear pad through polyurethane foam to periauricular skin over four hours is almost certainly lower than the 100 micrograms per kilogram administered in that study. The 16x ratio describes what happens to BPA once it crosses the skin. It does not tell us how much crosses.
This is a ten-person study — small by epidemiological standards, standard for pharmacokinetic research — conducted by the US EPA and NIEHS with FDA oversight, published in the peer-reviewed journal Environment International.7 The mechanism it demonstrates — first-pass metabolic bypass for dermally absorbed compounds — is the foundational principle of all transdermal drug delivery, corroborated by decades of pharmaceutical science8 and computationally supported by Liu and colleagues' PBPK modelling of dermal bisphenol kinetics.26 No independent human replication exists. This is a genuine limitation. It is not a refutation.
No epidemiological study has ever linked headphone use to adverse health outcomes from chemical exposure [epidemiological]. No biomonitoring study has stratified BPA levels by headphone usage. Nobody has looked. The absence of evidence reflects the absence of investigation — not the absence of effect. This is structurally identical to BPA in food contact materials before 2010: decades of mass use, no epidemiological signal, then EFSA's own re-evaluation drove a 20,000-fold reduction in the tolerable daily intake.19
BPA exhibits non-monotonic dose-response curves — effects that can be stronger at low doses than at high doses — in more than 20% of experiments and at least one endpoint in over 30% of studies [in vitro, animal].27 This means "low dose" is not synonymous with "safe dose" for endocrine disruptors. However, EFSA's own 2021 assessment concluded that the evidence for non-monotonic dose-response was insufficient to change standard risk assessment methodology.27 The scientific debate is genuine.
The honest assessment is this: the conditions for pharmacokinetically significant exposure exist. The measurement to determine whether that exposure is clinically relevant does not. The gap is not in the science. The gap is in the measurement. And the measurement has not been taken because the regulatory classification does not require it.
What Would Change This Analysis
A controlled migration study would materially update this assessment. The study is describable: BPA, BPS, phthalate, and flame retardant migration from commercial headphone ear pads — new and aged (2+ years) — into standardised artificial sweat (ISO 3160-2) supplemented with a sebum simulant, at 37°C, under simulated occlusion, over four-hour sessions. If migration rates under these conditions prove to be orders of magnitude below the dermal doses shown to produce the pharmacokinetic effects documented in Thayer and colleagues' study, the Accidental Patch framework would lose its urgency for headphones specifically — while remaining valid for products with confirmed higher migration rates.
An independent pharmacokinetic replication — a second controlled human study of dermal versus oral BPA bioavailability — would strengthen or weaken the load-bearing 16x finding. If the ratio holds in a larger sample with a more physiologically relevant application method (polymer contact rather than solution), the case becomes substantially stronger. If the ratio narrows significantly, the differentiation between headphone dermal exposure and other BPA exposure routes weakens.
If any headphone manufacturer has conducted internal migration testing, publishing the results would materially change this analysis. Sennheiser's statement — that its headphones undergo "rigorous testing to ensure applicable safety and quality standards" — implies some testing occurs.1 If that testing includes BPA migration data for skin-contact components, releasing it would either confirm or challenge the concerns documented here.
The study would cost approximately $2,000-4,000.22 Its non-existence is the finding.
The Levers
Tier 1: No Cost — Start Now
Replace ear pads at the first sign of degradation. When the surface cracks, flakes, or crumbles, you are not losing comfort. You are seeing the hydrolysis clock advance — the polyurethane barrier thinning, degradation products releasing, microplastic particles forming at the skin surface. Visible degradation is a chemical exposure signal. Replace promptly.
Use fabric or mesh ear pad covers. A textile barrier between polymer and skin disrupts direct contact. It interrupts the sebum-mediated extraction mechanism by preventing lipophilic skin secretions from coating the polymer surface. Some headphone models accept washable fabric covers; third-party options exist for most over-ear models.
Clean ear pads regularly. Wipe down with a damp cloth after use. Sebum accumulates on the ear pad surface over time, creating a persistent extraction medium even when headphones are not being worn. Removing the oily residue reduces the chemical bridge between polymer and skin.
Reconsider headphones during exercise. Exercise combines peak sebaceous output, acidic perspiration, elevated skin temperature, and vasodilation — the maximum chemical extraction conditions. For exercise, bone conduction headphones (which sit on the cheekbone, not over the ear) or speakers eliminate ear pad occlusion entirely.
Ventilate headphones between uses. Storing headphones in closed cases immediately after sweaty use traps moisture in the foam, accelerating hydrolysis. Allow ear pads to air-dry between sessions.
Tier 2: Replacement — When You Are Replacing Anyway
Choose headphones with fabric or woven-mesh ear pads over synthetic leather or polyurethane foam. Textile surfaces reduce direct polymer-to-skin contact and disrupt the occluded microenvironment that enhances chemical extraction.
Choose metal, wood, or Tritan copolyester housings over polycarbonate where available. These materials do not contain BPA as a structural component. Eastman Tritan is specifically marketed as a BPA-free alternative for headphone applications.5
Choose medical-grade silicone ear tips for in-ear earbuds. Silicone is BPA-free, does not hydrolyse, and is the same material used in pharmaceutical and medical devices designed for prolonged body contact.
Ask the question: "What polymer is the ear pad made from? Has it been tested for BPA migration under skin-contact conditions?" No brand currently answers this. The question itself — asked publicly, asked in reviews, asked at point of purchase — creates the market signal that does not yet exist.